… versus warfarin in nonvalvular atrial fibrillation patients with a previous history of stroke/…
with their respective phase III trials and previous stroke/transient ischemic attack subgroup …

… Zoom Image Figure 3: Hazard ratio of stroke/SE and major bleeding for propensity score
matched apixaban and warfarin patients. CI: confidence interval; SE: systemic embolism; GI: …

… In addition, this study shows that the benefits of apixaban over warfarin were consistent with
regard to stroke/SE, intracranial hemorrhage, mortality, and major bleeding, irrespective of …

… The benefits of apixaban versus warfarin for stroke and systemic embolism were similar in …
prior analysis and suggest that in patients with AF and at least 1 additional risk factor for stroke …

… on stroke prevention treatment with apixaban versus warfarin in patients with atrial fibrillation…
Results demonstrated no significant associations between cancer history and risk of stroke/…

… More patients in the apixaban group had prior stroke, transient ischemic attack, or systemic
embolism than those in the warfarin group (27.6% vs 17.4%), but that difference was not …

… This is relevant because first, patients with previous stroke or … patients who were newly
diagnosed with atrial fibrillation … Patients were categorized by anticoagulant drug first used …

… , the efficacy and safety of apixaban compared with warfarin were preserved in this high-risk …
the use of apixaban for stroke prevention in atrial fibrillation among vulnerable patients with …

… In this context, we performed a post hoc analysis of the ARISTOTLE trial (apixaban for
reduction of stroke and other thromboembolic events in atrial fibrillation) to assess the association …

… In a previous systematic review and meta-… versus warfarin in patients with atrial fibrillation
(AF) and stroke or transient ischemic attack (TIA). This meta-analysis included trials of apixaban…